- $10.31bn
- $32.96bn
- $10.82bn
Stabilisation Notice
Arcus Biosciences drops after starting stock offering
Disc Medicine down after $450 mln equity raise following rare disease drug trial success
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Jefferies shares remain undervalued, Oppenheimer says
Disc Medicine dips after launching $350 mln stock offering
US STOCKS ON THE MOVE-CoreWeave, Moderna, Datadog
U.S. STOCKS ON THE MOVE-Amazon, CoreWeave, Moderna
Jefferies Financial slips as annual investor day underway
Media: Banks vie for $4.25 billion debt financing to back Lantheus deal - Bloomberg News
Vaxcyte edges lower after $1 bln raise to fund pneumococcal vaccine
Vaxcyte down after starting $1 bln stock, convertible offerings
Spyre Therapeutics slips on $350 mln share sale
US RESEARCH ROUNDUP-Acuity, Dell Technologies, Nike
Jefferies Financial Group Inc reports results for the quarter ended May 31 - Earnings Summary
Jefferies' record equities haul offsets asset management slump (updated)
Corrected: Jefferies Q3 revenue beats estimates on growth in advisory, underwriting fees
Corrected: BRIEF-Jefferies Q3 Revenue USD 2,221.934 Million